Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Latest News about Can/Fite BioPharma Ltd/ Recent news which mentions Can/Fite BioPharma Ltd/ Multiple Shots On Goal: Can-Fite's Late-Stage Clinical Pipeline Hits Positive Results December 13, 2022 Tickers CANF Tags Biotech CANF Can/Fite BioPharma Ltd/ From Benzinga This Company Is Racing Toward Providing Comfort And Safety To Millions Of Psoriasis Sufferers October 27, 2022 Tickers AMGN BMY CANF Tags General BMY Partner Content From Benzinga Attacking Diseases On Multiple Fronts — Pharmaceutical Development Combined With Cannabis? April 12, 2022 Tickers ABBV AMGN CANF NVS Tags Biotech Can/Fite BioPharma Ltd/ Benzinga From Benzinga This Biotech Company Looks To Be Targeting A New Drug To Treat NASH, The Leading Cause of Liver Transplants March 24, 2022 Tickers AMGN CANF NVS Tags Market News NVS CANF From Benzinga Psoriasis Drug Providers Looking Over Shoulders At Upcoming Competitor? February 03, 2022 Tickers ABBV AMGN BMY CANF Tags Benzinga Can/Fite BioPharma Ltd/ Biotech From Benzinga A New Oral Therapy for Psoriasis Could Be Coming Soon January 24, 2022 Tickers ABBV AMGN CANF NVS Tags AMGN ABBV Penny Stocks From Benzinga PRIOR TO PHASE III PSORIASIS DATA RELEASE CAN FITE REPORTS THAT PICLIDENOSON DESTROYS PATHOLOGICAL SKIN CELLS IN VITRO January 13, 2022 Tickers CANF Tags Can/Fite BioPharma Ltd/ CANF Biotech From Benzinga Can-Fite to Conduct Investor Meetings during the J.P. Morgan Healthcare Conference January 10, 2022 Tickers CANF CFBI Tags Health Care Penny Stocks CFBI From Benzinga Dawson James - Can-Fite (CANF) Buy Rated - Expected Milestones January 05, 2022 Tickers CANF Tags Partner Content Benzinga Market News From Benzinga CAN-FITE ISSUES LETTER TO SHAREHOLDERS January 05, 2022 Tickers CANF Tags Market News Partner Content General From Benzinga FOLLOWING COMPLETE CLEARANCE OF CANCER LESIONS IN ADVANCED LIVER CANCER PATIENT, CAN-FITE IS FILING PATENT APPLICATIONS FOR THE TREATMENT OF VARIOUS ADVANCED SOLID TUMORS January 03, 2022 Tickers CANF Tags Partner Content Market News General From Benzinga Positive Data from Phase IIa Can-Fite NASH Study Published in Leading Peer Reviewed Scientific Journal October 21, 2021 Tickers CANF CFBI Tags Penny Stocks Benzinga CFBI From Benzinga Hope on the Horizon for Liver Cancer Patients as This Company's Namodenoson Drug Starts Pivotal Phase III Global Trial October 08, 2021 Tickers CANF Tags General Market News Partner Content From Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.